Life Sciences Tools and Services
Company Overview of Complete Genomics, Inc.
Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company’s human genome sequencing services are used in various applications, including cancer research, Mendelian disease research, rare variant disease research, translational research, clinical trial optimization, and companion diagnostic discovery. It serves academic research centers, government research centers, bio...
2071 Stierlin Court
Mountain View, CA 94043
Founded in 2005
Key Executives for Complete Genomics, Inc.
Co-Founder and Chief Scientific Officer
Co-Founder and Vice President of Financial Operations
Vice President of Operations
Compensation as of Fiscal Year 2013.
Complete Genomics, Inc. Key Developments
Complete Genomics, Inc. Announces Highly-Accurate Whole Genome Sequencing Technology
Sep 30 13
Complete Genomics, Inc. announced that its highly-accurate whole genome sequencing technology played a pivotal role in identifying a point mutation that causes Prader-Willi Syndrome (PWS). That discovery helped resolve a diagnostic conundrum for four young male patients. These data were published in Nature Genetics. PWS is a rare genetic disorder that causes poor muscle tone, low levels of sex hormones, and a constant feeling of hunger, according to the Eunice Kennedy Shriver National Institute of Child Health and Human Development. As a result, people with this condition tend to overeat, leading to obesity. The first patient in this study was tested for PWS when he was one year old, but the result was negative. Over the next 12 years, he began to manifest some, but not all, of the typical PWS symptoms. Then the patient met with paper author Dr. C. Thomas Caskey, who was director and chief executive officer of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, part of the University of Texas Health Science Center at Houston. Dr. Caskey has since joined Baylor College of Medicine as professor of molecular and human genetics. As MAGEL2 is only expressed on the paternal gene, it was important to determine whether the mutation was on the maternal or paternal version of chromosome 15. In this case, the MAGEL2 mutation was confirmed to be on the paternal gene using a modified version of Complete Genomics' Long Fragment Read technology.
Complete Genomics Appoints Ethan Knowlden as Senior Vice President, General Counsel, and Secretary
Sep 27 13
Complete Genomics, Inc. appointed Ethan Knowlden as senior vice president, general counsel, and secretary. Knowlden joins Complete from Novartis Vaccines and Diagnostics, Inc. where he served as vice president of business development and licensing, and corporate counsel.
Complete Genomics, Inc. Appoints Ethan Knowlden as Senior Vice President, General Counsel, and Secretary
Sep 17 13
Complete Genomics, Inc. announced that it has appointed Ethan Knowlden as senior vice president, general counsel, and secretary. Knowlden joins Complete from Novartis Vaccines and Diagnostics, Inc. where he served as vice president of business development and licensing, and corporate counsel. Prior to his more than 13 years of corporate experience with Novartis, and its predecessor Chiron Corp., Knowlden spent seven years in private practice.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|